Specialists for Indolent systemic mastocytosis

38 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Mariana Castells
Rare Disease / Clinical Research
Division of Allergy and Clinical Immunology
QC-verified 5
Tracy I George
Rare Disease / Clinical Research
Associated Regional and University Pathologists
QC-verified 5
Karin Hartmann, SLP
Rare Disease / Clinical Research
University Hospital Basel and University of Basel
DENVER, CO
QC-verified 5
Frank Siebenhaar
Rare Disease / Clinical Research
Institute of Allergology
QC-verified 7
Sonia Cerquozzi, M.D
Rare Disease / Clinical Research
University of Calgary
ROCHESTER, MN
QC-verified 3
Cem Akin, MD
Rare Disease / Clinical Research
Division of Allergy and Clinical Immunology
NORTHVILLE, MI
QC-verified 8
Cecilia Arana Yi
Rare Disease / Clinical Research
Mayo Clinic
QC-verified 3
Andreas Reiter
Rare Disease / Clinical Research
University Hospital Mannheim
QC-verified 3
Ingunn Dybedal
Rare Disease / Clinical Research
Oslo University Hospital
QC-verified 3
Peter Valent
Rare Disease / Clinical Research
Medical University of Vienna
QC-verified 4
Vito Sabato
Rare Disease / Clinical Research
Antwerp University Hospital
QC-verified 4
Sigurd Broesby-Olsen
Rare Disease / Clinical Research
Mastocytosis Centre
QC-verified 4
Marcus Maurer, MD
Charite University, Berlin, Germany
PI×6
Frank Siebenhaar, MD
Rare Disease / Clinical Research
Charite University, Berlin, Germany
PI×2
Olivier Lortholary, MD, PhD
Rare Disease / Clinical Research
Hôpital Necker, Paris, France
PI×5
Rachael Easton, MD, PhD, FNP-BC
Rare Disease / Clinical Research
Cogent Biosciences
TROY, MI
PI×3
Hirsh D Komarow, M.D., M.D
Rare Disease / Clinical Research
National Institute of Allergy and Infectious Diseases (NIAID)
BETHESDA, MD
PI×3
Cristina Bulai Livideanu, MD
Rare Disease / Clinical Research
University Hospital, Toulouse
PI×3
Anthony L Boral, MD, PhD, M.D
Rare Disease / Clinical Research
Blueprint Medicines Corporation
CAMBRIDGE, MA
PI×1
Ilda Bidollari
Rare Disease / Clinical Research
Blueprint Medicines Corporation
4
Brenton Mar, MD, PhD
Rare Disease / Clinical Research
Blueprint Medicines Corporation
BOSTON, MA
3
Hui-Min Lin
Rare Disease / Clinical Research
Blueprint Medicines Corporation
3
Alan L Shields
Rare Disease / Clinical Research
Adelphi Values
MA
3
Tanya Green
Rare Disease / Clinical Research
Blueprint Medicines
MA
3
Brad Padilla
Rare Disease / Clinical Research
Adelphi Values
MA
3
Fiona Taylor
Rare Disease / Clinical Research
Adelphi Values
MA
3
Philippe Schafhausen
Rare Disease / Clinical Research
University Medical Center Hamburg-Eppendorf
2
Aleksandra Górska
Rare Disease / Clinical Research
Medical University of Gdansk
3
Alberto Orfao
Rare Disease / Clinical Research
Cancer Research Center (The Institute of Cancer Molecular and Cellular Biology
3
Jonathan J Lyons
Rare Disease / Clinical Research
University of California San Diego
3
J.C. Kluin-Nelemans
University Medical Center Groningen
QC-verified PI×1
Mark Rafferty, OD
The Beatson West of Scotland Cancer Centre
2
Marta Gruchała-Niedoszytko
Rare Disease / Clinical Research
linical Nutrition
3
Johanna Ungerstedt
Rare Disease / Clinical Research
Karolinska University Hospitale
2
Mattias Mattsson
Rare Disease / Clinical Research
Uppsala University Hospital and Department of Immunology
2
Celalettin Ustun, MD
Rare Disease / Clinical Research
Rush Medical College
CHICAGO, IL
2
Paul Van Daele
Rare Disease / Clinical Research
Erasmus Medical Center
2
Iván Alvarez-Twose
Rare Disease / Clinical Research
Hospital Virgen del Valle
2

More about Indolent systemic mastocytosis